[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Benign Prostatic Hyperplasia (BPH) Treatment Devices Market - Global Outlook and Forecast 2021-2027

April 2021 | 100 pages | ID: B102C869CF01EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Benign Prostatic Hyperplasia (BPH) Treatment Devices in global, including the following market information:

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Sales, 2016-2021, 2022-2027, (K Units)

Global top five Benign Prostatic Hyperplasia (BPH) Treatment Devices companies in 2020 (%)

The global Benign Prostatic Hyperplasia (BPH) Treatment Devices market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Benign Prostatic Hyperplasia (BPH) Treatment Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segment Percentages, By Type, 2020 (%)
  • Surgical Treatment
  • Minimally Invasive Treatment
  • Laser Treatment
  • Other
Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segment Percentages, By Application, 2020 (%)
  • Fertility Clinics
  • Hospitals
  • Others
Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Benign Prostatic Hyperplasia (BPH) Treatment Devices revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Benign Prostatic Hyperplasia (BPH) Treatment Devices revenues share in global market, 2020 (%)

Key companies Benign Prostatic Hyperplasia (BPH) Treatment Devices sales in global market, 2016-2021 (Estimated), (K Units)

Key companies Benign Prostatic Hyperplasia (BPH) Treatment Devices sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Advin Urology
  • Biolitec
  • Boston Scientific Corporation
  • CONMED
  • Convergent Laser Technologies
  • CoreTherm Medical, Inc. (ProstaLund)
  • HistoSonics, Inc.
  • JenaSurgical GmbH
  • KARL STORZ
  • LISA Laser Products GmbH
  • Lumenis Ltd.
  • Medifocus, Inc.
  • Endo International
  • Medtronic
  • Siemens
  • Olympus
  • Urologix
  • NeoTract
  • Urotech
  • Baxter International
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES OVERALL MARKET SIZE

2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size: 2021 VS 2027
2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Players in Global Market
3.2 Top Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Companies Ranked by Revenue
3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Companies
3.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Companies
3.5 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Benign Prostatic Hyperplasia (BPH) Treatment Devices Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type
3.8 Tier 1, Tier 2 and Tier 3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Players in Global Market
  3.8.1 List of Global Tier 1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Companies
  3.8.2 List of Global Tier 2 and Tier 3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Markets, 2021 & 2027
  4.1.2 Surgical Treatment
  4.1.3 Minimally Invasive Treatment
  4.1.4 Laser Treatment
  4.1.5 Other
4.2 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue & Forecasts
  4.2.1 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2021
  4.2.2 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2022-2027
  4.2.3 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share, 2016-2027
4.3 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales & Forecasts
  4.3.1 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2021
  4.3.2 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2022-2027
  4.3.3 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share, 2016-2027
4.4 By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2021 & 2027
  5.1.2 Fertility Clinics
  5.1.3 Hospitals
  5.1.4 Others
5.2 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue & Forecasts
  5.2.1 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2021
  5.2.2 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2022-2027
  5.2.3 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share, 2016-2027
5.3 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales & Forecasts
  5.3.1 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2021
  5.3.2 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2022-2027
  5.3.3 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share, 2016-2027
5.4 By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2021 & 2027
6.2 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue & Forecasts
  6.2.1 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2021
  6.2.2 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2022-2027
  6.2.3 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share, 2016-2027
6.3 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales & Forecasts
  6.3.1 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2021
  6.3.2 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2022-2027
  6.3.3 By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2027
  6.4.2 By Country - North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2027
  6.4.3 US Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.4.4 Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.4.5 Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2027
  6.5.2 By Country - Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2027
  6.5.3 Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.5.4 France Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.5.5 U.K. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.5.6 Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.5.7 Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.5.8 Nordic Countries Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.5.9 Benelux Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2027
  6.6.2 By Region - Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2027
  6.6.3 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.6.4 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.6.5 South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.6.6 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.6.7 India Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2027
  6.7.2 By Country - South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2027
  6.7.3 Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.7.4 Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, 2016-2027
  6.8.3 Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.8.4 Israel Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.8.5 Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027
  6.8.6 UAE Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Advin Urology
  7.1.1 Advin Urology Corporate Summary
  7.1.2 Advin Urology Business Overview
  7.1.3 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.1.4 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.1.5 Advin Urology Key News
7.2 Biolitec
  7.2.1 Biolitec Corporate Summary
  7.2.2 Biolitec Business Overview
  7.2.3 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.2.4 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.2.5 Biolitec Key News
7.3 Boston Scientific Corporation
  7.3.1 Boston Scientific Corporation Corporate Summary
  7.3.2 Boston Scientific Corporation Business Overview
  7.3.3 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.3.4 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.3.5 Boston Scientific Corporation Key News
7.4 CONMED
  7.4.1 CONMED Corporate Summary
  7.4.2 CONMED Business Overview
  7.4.3 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.4.4 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.4.5 CONMED Key News
7.5 Convergent Laser Technologies
  7.5.1 Convergent Laser Technologies Corporate Summary
  7.5.2 Convergent Laser Technologies Business Overview
  7.5.3 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.5.4 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.5.5 Convergent Laser Technologies Key News
7.6 CoreTherm Medical, Inc. (ProstaLund)
  7.6.1 CoreTherm Medical, Inc. (ProstaLund) Corporate Summary
  7.6.2 CoreTherm Medical, Inc. (ProstaLund) Business Overview
  7.6.3 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.6.4 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.6.5 CoreTherm Medical, Inc. (ProstaLund) Key News
7.7 HistoSonics, Inc.
  7.7.1 HistoSonics, Inc. Corporate Summary
  7.7.2 HistoSonics, Inc. Business Overview
  7.7.3 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.4.4 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.7.5 HistoSonics, Inc. Key News
7.8 JenaSurgical GmbH
  7.8.1 JenaSurgical GmbH Corporate Summary
  7.8.2 JenaSurgical GmbH Business Overview
  7.8.3 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.8.4 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.8.5 JenaSurgical GmbH Key News
7.9 KARL STORZ
  7.9.1 KARL STORZ Corporate Summary
  7.9.2 KARL STORZ Business Overview
  7.9.3 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.9.4 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.9.5 KARL STORZ Key News
7.10 LISA Laser Products GmbH
  7.10.1 LISA Laser Products GmbH Corporate Summary
  7.10.2 LISA Laser Products GmbH Business Overview
  7.10.3 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.10.4 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.10.5 LISA Laser Products GmbH Key News
7.11 Lumenis Ltd.
  7.11.1 Lumenis Ltd. Corporate Summary
  7.11.2 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Business Overview
  7.11.3 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.11.4 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.11.5 Lumenis Ltd. Key News
7.12 Medifocus, Inc.
  7.12.1 Medifocus, Inc. Corporate Summary
  7.12.2 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Business Overview
  7.12.3 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.12.4 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.12.5 Medifocus, Inc. Key News
7.13 Endo International
  7.13.1 Endo International Corporate Summary
  7.13.2 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Business Overview
  7.13.3 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.13.4 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.13.5 Endo International Key News
7.14 Medtronic
  7.14.1 Medtronic Corporate Summary
  7.14.2 Medtronic Business Overview
  7.14.3 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.14.4 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.14.5 Medtronic Key News
7.15 Siemens
  7.15.1 Siemens Corporate Summary
  7.15.2 Siemens Business Overview
  7.15.3 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.15.4 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.15.5 Siemens Key News
7.16 Olympus
  7.16.1 Olympus Corporate Summary
  7.16.2 Olympus Business Overview
  7.16.3 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.16.4 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.16.5 Olympus Key News
7.17 Urologix
  7.17.1 Urologix Corporate Summary
  7.17.2 Urologix Business Overview
  7.17.3 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.17.4 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.17.5 Urologix Key News
7.18 NeoTract
  7.18.1 NeoTract Corporate Summary
  7.18.2 NeoTract Business Overview
  7.18.3 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.18.4 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.18.5 NeoTract Key News
7.19 Urotech
  7.19.1 Urotech Corporate Summary
  7.19.2 Urotech Business Overview
  7.19.3 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.19.4 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.19.5 Urotech Key News
7.20 Baxter International
  7.20.1 Baxter International Corporate Summary
  7.20.2 Baxter International Business Overview
  7.20.3 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Product Offerings
  7.20.4 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Revenue in Global (2016-2021)
  7.20.5 Baxter International Key News

8 GLOBAL BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES PRODUCTION CAPACITY, ANALYSIS

8.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity, 2016-2027
8.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity of Key Manufacturers in Global Market
8.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 BENIGN PROSTATIC HYPERPLASIA (BPH) TREATMENT DEVICES SUPPLY CHAIN ANALYSIS

10.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry Value Chain
10.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Upstream Market
10.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Benign Prostatic Hyperplasia (BPH) Treatment Devices in Global Market
Table 2. Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Share by Companies, 2016-2021
Table 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Companies, (K Units), 2016-2021
Table 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (2016-2021) & (US$/Unit)
Table 8. Global Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type
Table 9. List of Global Tier 1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), 2016-2021
Table 15. By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), 2022-2027
Table 16. By Application – Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), 2016-2021
Table 20. By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), 2022-2027
Table 21. By Region – Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), 2016-2021
Table 25. By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), 2022-2027
Table 26. By Country - North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, (K Units), 2016-2021
Table 29. By Country - North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, (K Units), 2022-2027
Table 30. By Country - Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, (K Units), 2016-2021
Table 33. By Country - Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, (K Units), 2022-2027
Table 34. By Region - Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, (K Units), 2016-2021
Table 37. By Region - Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, (K Units), 2022-2027
Table 38. By Country - South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, (K Units), 2016-2021
Table 41. By Country - South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, (K Units), 2022-2027
Table 46. Advin Urology Corporate Summary
Table 47. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 48. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 49. Biolitec Corporate Summary
Table 50. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 51. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 52. Boston Scientific Corporation Corporate Summary
Table 53. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 54. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 55. CONMED Corporate Summary
Table 56. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 57. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 58. Convergent Laser Technologies Corporate Summary
Table 59. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 60. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 61. CoreTherm Medical, Inc. (ProstaLund) Corporate Summary
Table 62. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 63. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 64. HistoSonics, Inc. Corporate Summary
Table 65. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 66. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 67. JenaSurgical GmbH Corporate Summary
Table 68. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 69. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 70. KARL STORZ Corporate Summary
Table 71. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 72. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 73. LISA Laser Products GmbH Corporate Summary
Table 74. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 75. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 76. Lumenis Ltd. Corporate Summary
Table 77. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 78. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 79. Medifocus, Inc. Corporate Summary
Table 80. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 81. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 82. Endo International Corporate Summary
Table 83. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 84. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 85. Medtronic Corporate Summary
Table 86. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 87. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 88. Siemens Corporate Summary
Table 89. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 90. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 91. Olympus Corporate Summary
Table 92. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 93. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 94. Urologix Corporate Summary
Table 95. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 96. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 97. NeoTract Corporate Summary
Table 98. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 99. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 100. Urotech Corporate Summary
Table 101. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 102. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 103. Baxter International Corporate Summary
Table 104. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Offerings
Table 105. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 106. Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 107. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Capacity Market Share of Key Manufacturers, 2019-2021
Table 108. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production by Region, 2016-2021 (K Units)
Table 109. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production by Region, 2022-2027 (K Units)
Table 110. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Opportunities & Trends in Global Market
Table 111. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Drivers in Global Market
Table 112. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Restraints in Global Market
Table 113. Benign Prostatic Hyperplasia (BPH) Treatment Devices Raw Materials
Table 114. Benign Prostatic Hyperplasia (BPH) Treatment Devices Raw Materials Suppliers in Global Market
Table 115. Typical Benign Prostatic Hyperplasia (BPH) Treatment Devices Downstream
Table 116. Benign Prostatic Hyperplasia (BPH) Treatment Devices Downstream Clients in Global Market
Table 117. Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Type
Figure 2. Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Application
Figure 3. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, 2016-2027 (US$, Mn)
Figure 7. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue in 2020
Figure 9. By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share, 2016-2027
Figure 10. By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share, 2016-2027
Figure 11. By Type - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (US$/Unit), 2016-2027
Figure 12. By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share, 2016-2027
Figure 13. By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share, 2016-2027
Figure 14. By Application - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price (US$/Unit), 2016-2027
Figure 15. By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share, 2016-2027
Figure 16. By Region - Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share, 2016-2027
Figure 17. By Country - North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share, 2016-2027
Figure 18. By Country - North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share, 2016-2027
Figure 19. US Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share, 2016-2027
Figure 24. Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 25. France Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share, 2016-2027
Figure 33. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 37. India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share, 2016-2027
Figure 39. By Country - South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share, 2016-2027
Figure 40. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share, 2016-2027
Figure 44. Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue, (US$, Mn), 2016-2027
Figure 48. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Benign Prostatic Hyperplasia (BPH) Treatment Devices by Region, 2020 VS 2027
Figure 50. Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry Value Chain
Figure 51. Marketing Channels


More Publications